BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26864276)

  • 1. SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment.
    Shi M; He J
    Mol Biosyst; 2016 Apr; 12(4):1214-23. PubMed ID: 26864276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer adjuvant chemotherapy strategic classification by artificial neural network with gene expression data: An example for non-small cell lung cancer.
    Chen YC; Chang YC; Ke WC; Chiu HW
    J Biomed Inform; 2015 Aug; 56():1-7. PubMed ID: 25998519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning models in breast cancer survival prediction.
    Montazeri M; Montazeri M; Montazeri M; Beigzadeh A
    Technol Health Care; 2016; 24(1):31-42. PubMed ID: 26409558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.
    Di Leo A; Desmedt C; Bartlett JM; Piette F; Ejlertsen B; Pritchard KI; Larsimont D; Poole C; Isola J; Earl H; Mouridsen H; O'Malley FP; Cardoso F; Tanner M; Munro A; Twelves CJ; Sotiriou C; Shepherd L; Cameron D; Piccart MJ; Buyse M;
    Lancet Oncol; 2011 Nov; 12(12):1134-42. PubMed ID: 21917518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAEROF: an ensemble approach for large-scale drug-disease association prediction by incorporating rotation forest and sparse autoencoder deep neural network.
    Jiang HJ; Huang YA; You ZH
    Sci Rep; 2020 Mar; 10(1):4972. PubMed ID: 32188871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topologically inferring pathway activity for precise survival outcome prediction: breast cancer as a case.
    Liu W; Wang W; Tian G; Xie W; Lei L; Liu J; Huang W; Xu L; Li E
    Mol Biosyst; 2017 Feb; 13(3):537-548. PubMed ID: 28098303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer.
    Sonnenblick A; Uziely B; Nechushtan H; Kadouri L; Galun E; Axelrod JH; Katz D; Daum H; Hamburger T; Maly B; Allweis TM; Peretz T
    Breast Cancer Res Treat; 2013 Apr; 138(2):407-13. PubMed ID: 23446809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transfer learning approach via procrustes analysis and mean shift for cancer drug sensitivity prediction.
    Turki T; Wei Z; Wang JTL
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840014. PubMed ID: 29945499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting response to chemotherapy with early-stage lung cancer.
    Rosell R; Taron M; Massuti B; Mederos N; Magri I; Santarpia M; Sanchez JM
    Cancer J; 2011; 17(1):49-56. PubMed ID: 21263267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.
    Steele SR; Bilchik A; Johnson EK; Nissan A; Peoples GE; Eberhardt JS; Kalina P; Petersen B; BrĂ¼cher B; Protic M; Avital I; Stojadinovic A
    Am Surg; 2014 May; 80(5):441-53. PubMed ID: 24887722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
    Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
    Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
    Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
    Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
    Bertucci F; Borie N; Roche H; Bachelot T; Le Doussal JM; Macgrogan G; Debono S; Martinec A; Treilleux I; Finetti P; Esterni B; Extra JM; Geneve J; Hermitte F; Chabannon C; Jacquemier J; Martin AL; Longy M; Maraninchi D; Fert V; Birnbaum D; Viens P
    Breast Cancer Res Treat; 2011 Jun; 127(2):363-73. PubMed ID: 20585850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convolutional neural network approach to lung cancer classification integrating protein interaction network and gene expression profiles.
    Matsubara T; Ochiai T; Hayashida M; Akutsu T; Nacher JC
    J Bioinform Comput Biol; 2019 Jun; 17(3):1940007. PubMed ID: 31288636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.